Redesigning the way patients take their medication

Radically improve adherence
& strengthen patient-provider relationships.

Health coaches and providers use our HIPAA-compliant platform to engage with patients and track dose-by-dose medication adherence with video Directly Observed Therapy (DOT).

Request a Demo

Directly Observed Therapy (DOT) is the most effective way to ensure medication adherence.1 By digitizing the process with video DOT, emocha has made this practice more accessible and scalable. Public health departments and academic medical centers have evaluated emocha with support from the National Institute on Minority Health and Health Disparities, the National Institute on Drug Abuse, and the Patient Centered Outcomes Research Institute.

1 Sbarbaro JA. Compliance: inducements and enforcements. Chest 1979; 6 (suppl): 750-56; Sbarbaro JA. The nature of man and physician. Am Rev Respir Dis 1981; 123: 247; Sbarbaro JA. All patients should receive directly observed therapy in tuberculosis. Am Rev Respir Dis 1988; 138: 1075-76.

Public Health Case Studies

Hepatitis C

Quick view

Tuberculosis

Quick view

Opioid Use Disorder

Quick view
×

Hepatitis C

For a standard 12-week regimen, hepatitis C (HCV) medications can cost upwards of $40,000. One in four patients is denied coverage upon initial request if they are expected to be nonadherent.

Solution: Verified records of adherence can help reduce the barriers patients face to prior authorization and give providers the confidence to prescribe treatment.

Massachusetts General Hospital, Harvard Medical School’s largest teaching hospital, is one of the leading academic medical centers using emocha to support people who inject drugs and are receiving HCV treatment.

×

Tuberculosis

DOT is the standard of care for tuberculosis (TB) treatment, but it can be costly and time-consuming. Infectious Diseases Society of America guidelines acknowledge video DOT as an alternative to in-person DOT that can support health departments facing staffing shortages and budget limitations.

Solution: Secure, asynchronous video DOT allows patients and providers to complete DOT on their own schedule, dramatically reducing the cost of travel for providers and minimizing the impact on patient’s lives.

Harris County, Texas has used emocha for active and latent TB treatment with over 400 patients since 2014.

×

Opioid use disorder

Medication-assisted treatment (MAT) can be delivered with take-home buprenorphine, but research suggests only 20 percent of patients with an opioid use disorder receive any treatment. Concerns about adherence is one barrier to prescribing buprenorphine.

Solution: emocha’s HIPAA-compliant mobile technology provides dose-by-dose adherence verification and tools for patient engagement. Our platform gives providers the assurance that their patients are supported and successful in treatment and notifies them when patients need additional assistance.

Opioid treatment programs like Pathway Healthcare leverage emocha at clinics across the country.

×

HIV & PrEP

The World Health Organization (WHO) has made it a priority to identify strategies that improve antiretroviral treatment adherence and long-term care retention for people with HIV. Similarly, the U.S. Centers for Disease Control and Prevention have made significant investments to connect individuals to Pre-exposure Prophylaxis, known as PrEP, for HIV prevention.

Solution: Health coaches in three cities use emocha to link patients to care and provide support during vulnerable times. According to the NIH, the savings would reach $338,400 per patient if all HIV-infected individuals presented early and remained in care, staying adherent to their medication. (Source)

In Baltimore City, Philadelphia, and Washington, D.C., health coaches have used emocha to link hundreds of patients to treatment for HIV and PrEP.

Partner with us

Patients get better faster, public health resources go further

We’re on a mission to reduce the prevalence of tuberculosis, hepatitis C, HIV, and opioid use disorder. Our technology is built specifically to enable public health experts help their patients get better, faster. emocha is the leader in video DOT, used by public health departments around the country and all over the world.

Improve outcomes with the best-in-class medication adherence platform

Managed Care Organizations can leverage emocha to efficiently engage their Medicaid and Medicare populations. Taking a dose-by-dose approach to medication adherence is a competitive advantage that results in more engaged patients and providers, and improved health outcomes.

Enroll patients into emocha’s video Directly Observed Therapy (video DOT)

Ensure medication adherence through asynchronous support and verification at every single dose. Providers can monitor patient progress themselves, or allow internal or external staff to perform video DOT. Our cost-efficient platform easily adapts to organizational structure and workflow.

Medication adherence and autonomy achieved through patient-centric design

Our platform is designed around the needs of the patient. Whether the challenge is tuberculosis, opioid addiction, hepatitis C, or a chronic condition, emocha provides a novel form of engagement that radically improves adherence.Independent studies have proven that patients using emocha can achieve adherence rates of 90 percent and above, regardless of socioeconomic status, literacy, or age. Providers across the United States trust emocha with their most vulnerable patients.